figshare
Browse
13023_2017_712_MOESM3_ESM.docx (25.88 kB)

Additional file 3: Table S3. of Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)

Download (25.88 kB)
Version 3 2019-08-10, 04:42
Version 2 2019-06-10, 03:30
Version 1 2017-10-04, 03:47
journal contribution
posted on 2017-10-03, 05:00 authored by Joseph Muenzer, Roberto Giugliani, Maurizio Scarpa, Anna Tylki-Szymańska, Virginie Jego, Michael Beck
Summary of adverse events reported in patients who started treatment at or after Hunter Outcome Survey (HOS) entry (DOCX 25 kb)

History